Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
COLESTIPOL HYDROCHLORIDE (UNII: X7D10K905G) (COLESTIPOL - UNII:K50N755924)
ANI Pharmaceuticals, Inc.
ORAL
PRESCRIPTION DRUG
Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use. Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Generally, colestipol hydrochloride tablets have no clinically significant effect on serum triglycerides, but with their use, triglyceride levels may be raised in some patients. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Treatment should begin and continue with dietary therapy (see NCEP guidelines). A minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy. Shorter periods may be considere
Colestipol hydrochloride tablets USP, 1 gram are yellow, film-coated, elliptical tablets, debossed with “S” on one side and plain on the other. They are supplied as follows: Bottles of 120 NDC 62559-395-12 Each tablet contains 1 gram of micronized colestipol hydrochloride USP. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture.
Abbreviated New Drug Application
COLESTIPOL HYDROCHLORIDE- COLESTIPOL HYDROCHLORIDE TABLET, FILM COATED ANI PHARMACEUTICALS, INC. ---------- COLESTIPOL HYDROCHLORIDE TABLETS USP DESCRIPTION The active ingredient in colestipol hydrochloride tablets USP is micronized colestipol hydrochloride, which is a lipid lowering agent for oral use. Colestipol is an insoluble, high molecular weight basic anion-exchange copolymer of diethylenetriamine and 1-chloro-2, 3-epoxypropane, with approximately 1 out of 5 amine nitrogens protonated (chloride form). It is a light yellow water-insoluble resin which is hygroscopic and swells when suspended in water or aqueous fluids. Each colestipol hydrochloride tablet USP contains one gram of micronized colestipol hydrochloride. Colestipol hydrochloride tablets are yellow in color and are tasteless and odorless. Inactive ingredients: acetone, cellulose acetate phthalate, ethanol, magnesium stearate, microcrystalline cellulose, hypromellose, povidone, silicon dioxide and triacetin. CLINICAL PHARMACOLOGY Cholesterol is the major, and probably the sole precursor of bile acids. During normal digestion, bile acids are secreted via the bile from the liver and gall bladder into the intestines. Bile acids emulsify the fat and lipid materials present in food, thus facilitating absorption. A major portion of the bile acids secreted is reabsorbed from the intestines and returned via the portal circulation to the liver, thus completing the enterohepatic cycle. Only very small amounts of bile acids are found in normal serum. Colestipol hydrochloride binds bile acids in the intestine forming a complex that is excreted in the feces. This nonsystemic action results in a partial removal of the bile acids from the enterohepatic circulation, preventing their reabsorption. Since colestipol hydrochloride is an anion exchange resin, the chloride anions of the resin can be replaced by other anions, usually those with a greater affinity for the resin than the chloride ion. Colestipol hydrochloride is hydrophilic, but it is virtually water insol Preberite celoten dokument